Insulin resistance and oxidative stress in familial combined hyperlipidemia

Goldstein, 1973, Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction, J Clin Invest, 52, 1533, 10.1172/JCI107331 Goldstein, 1973, Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia, J Clin Invest, 52, 1544, 10.1172/JCI107332 Hazzard, 1973, Hyperlipidemia in coronary heart disease. III. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction, J Clin Invest, 52, 1569, 10.1172/JCI107333 Paoletti, 2004, Inflammation in atherosclerosis and implications for therapy, Circulation, 109, 20 Martinet, 2002, Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques, Circulation, 106, 927, 10.1161/01.CIR.0000026393.47805.21 Ascaso, 1998, A study of insulin resistance, using the minimal model, in non-diabetic familial combined hyperlipidemic patients, Metabolism, 47, 508, 10.1016/S0026-0495(98)90232-3 Ascaso, 1997, Influence of obesity on plasma lipoproteins, glycaemia and insulinaemia in patients with Familial combined hyperlipidaemia, Int J Obes, 21, 360, 10.1038/sj.ijo.0800413 Ascaso, 1997, Insulin resistance in patients with familial combined hyperlipidemia and ischemic heart disease, Am J Cardiol, 80, 1484, 10.1016/S0002-9149(97)00737-6 Papaharalambus, 2007, Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury, Trends Cardiovasc Med, 17, 48, 10.1016/j.tcm.2006.11.005 Smedly, 1986, Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase, J Clin Invest, 77, 1233, 10.1172/JCI112426 Weiss, 1989, Tissue destruction by neutrophils, N Engl J Med, 320, 365, 10.1056/NEJM198902093200606 Nourooz-Zadeh, 2001, Measures of oxidative stress in heterozygous familial hypercholesterolaemia, Atherosclerosis, 156, 435, 10.1016/S0021-9150(00)00677-8 Castro-Cabezas, 1992, Familial combined hyperlipidaemia: 1973–1991, Nether J Med, 40, 83 Ascaso, 2001, Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population, Med Clin (Barc), 117, 530, 10.1016/S0025-7753(01)72168-9 Oltra, 2001, Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia, Free Radic Biol Med, 30, 1286, 10.1016/S0891-5849(01)00521-4 Navarro, 1997, Blood glutathione as an index of radiation-induced oxidative stress in mice and humans, Free Radic Biol Med, 22, 1203, 10.1016/S0891-5849(96)00554-0 Muniz, 1995, The role of 8-hydroxy-2′-deoxyguanosine in rifamycin-induced DNA damage, Free Radic Biol Med, 18, 747, 10.1016/0891-5849(94)00200-4 Nebot, 1993, Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol, Anal Biochem, 214, 442, 10.1006/abio.1993.1521 Aebi, 1984, Catalase in vitro, Methods Enzymol, 105, 121, 10.1016/S0076-6879(84)05016-3 Paglia, 1967, Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase, J Lab Clin Med, 70, 158 Heistad, 2006, Oxidative stress and vascular disease: 2005 Duff lecture, Arterioscler Thromb Vasc Biol, 26, 689, 10.1161/01.ATV.0000203525.62147.28 Spiekermann, 2003, Electron spin resonance characterization of vascular xhantine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation, Circulation, 107, 1383, 10.1161/01.CIR.0000056762.69302.46 Blankenberg, 2003, Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease, N Engl J Med, 349, 1595, 10.1056/NEJMoa030535 Dalle-Donne, 2006, Biomarkers of oxidative damage in human disease, Clin Chem, 52, 601, 10.1373/clinchem.2005.061408 Tsutsui, 2002, 8-oxo-dGTPase, which prevents oxidative stress-induced DNA damage, increases in the mitochondria from failing hearts, Circulation, 104, 2883, 10.1161/hc4901.101347 Andican, 2005, Oxidative damage to nuclear DNA in streptozotocin-diabetic rat liver, Clin Exp Pharmacol Physiol, 32, 663, 10.1111/j.0305-1870.2005.04247.x Stephens, 2006, Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males, Clin Chem, 52, 446, 10.1373/clinchem.2005.060194 Evans, 2002, Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes, Endocr Rev, 23, 599, 10.1210/er.2001-0039 Ceriello, 2004, Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited, Arterioscler Thromb Vasc Biol, 24, 816, 10.1161/01.ATV.0000122852.22604.78 Urakawa, 2003, Oxidative stress is associated with adiposity and insulin resistance in men, J Clin Endocrinol Metab, 88, 4673, 10.1210/jc.2003-030202 Dandona, 2003, The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes, J Clin Endocrinol Metab, 88, 2422, 10.1210/jc.2003-030178